Divalent metal transporter, iron, and Parkinson's disease: a pathological relationship. (Q53716933)

18 May 2018

title

Divalent metal transporter, iron, and Parkinson's disease: a pathological relationship. (English)

1 reference

18 May 2018

1 reference

5

1 reference

18 May 2018

Xiongwei Zhu

2

object named as

Xiongwei Zhu

1 reference

18 May 2018

6

Mark A Smith

1 reference

18 May 2018

Hyoung-gon Lee

7

object named as

Hyoung-gon Lee

1 reference

18 May 2018

Hyun-Pil Lee

1

object named as

Hyun-pil Lee

1 reference

18 May 2018

author name string

Gang Liu

3

1 reference

18 May 2018

Shu G Chen

4

1 reference

18 May 2018

publication date

1 April 2010

1 reference

18 May 2018

published in

Cell Research

1 reference

18 May 2018

volume

20

1 reference

18 May 2018

issue

4

1 reference

18 May 2018

page(s)

397-399

1 reference

18 May 2018

Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.39

Effect of hypoxia on the binding and subcellular distribution of iron regulatory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.39

Cloning and characterization of a mammalian proton-coupled metal-ion transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.39

Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.39

Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.39

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.39

Abnormal localization of iron regulatory protein in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.39

A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.39

Deferoxamine attenuates iron-induced oxidative stress and prevents mitochondrial aggregation and alpha-synuclein translocation in SK-N-SH cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.39

Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.39

Redox-active iron mediates amyloid-beta toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.39

In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.39

Nanoparticle and iron chelators as a potential novel Alzheimer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.39

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CR.2010.39

1 reference

18 May 2018

1 reference

18 May 2018